x.com路 @ 路 X路路 2026-04-22Score60
Body
馃敟馃敟Presented at #AACR26 by Dr Lyudmila Bazhenova @UCSDCancer impressive Duration of response for 1L
#taletrectenib for ROS1+ NSCLC #TRUST-I/II pooled analysis
N=157
ORR 90%
DoR 49.7mos鉂楋笍(4 yrs +)
mOS not reached
concurrent @JCO_ASCO publication 馃憞馃徑
馃摉 https://t.co/ifoFxaaRmk
@ros1cancer #lcsm
Heat 58 路 39 likes 路 2 replies 路 17 reposts
Source: x.com 路 x.com